Skip to main content
. 2019 Mar 8;17(5):4621–4625. doi: 10.3892/ol.2019.10129

Figure 2.

Figure 2.

Association of CLDN6 expression level with prognosis of gastric cancer patients. Kaplan-Meier was used to calculate the survival rate and log-rank test was used for the comparison of the survival curves. In this experiment, patients were divided into the CLDN6 high-expression group (≥1.42) with 107 patients and the CLDN6 low-expression group (<1.42) with 106 patients, with the median expression level of CLDN6 as the boundary. The 1-, 2- and 3-year survival rates of patients in the CLDN6 low-expression group were 80.19, 60.38 and 48.11%, respectively, and those in the CLDN6 high expression group were 87.85, 73.83 and 66.36%, respectively. CLDN6, claudin-6.